2,472 results on '"Tijssen, Jan"'
Search Results
2. Standards for quantitative assessments by coronary computed tomography angiography (CCTA): An expert consensus document of the society of cardiovascular computed tomography (SCCT)
3. Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study
4. Abstract 17748: Lipoprotein(a) and Oxidized Phospholipids on Lipoproteins and Cardiovascular Outcomes in Patients With Chronic Coronary Syndrome Treated With Colchicine
5. Abstract 17486: Non-Proportional Hazards in Randomized Cardiology Clinical Trials: A Standardized Universal Secondary Analysis (SUSAN) to Enhance Clinically Meaningful Appraisal of Results
6. Fractional flow reserve or 3D-quantitative-coronary-angiography based vessel-FFR guided revascularization. Rationale and study design of the prospective randomized fast III trial
7. The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial
8. Impact of core laboratory assessment on treatment decisions and clinical outcomes using combined fractional flow reserve and coronary flow reserve measurements – DEFINE-FLOW core laboratory sub-study
9. Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial
10. Uso de registros cardiovasculares en procesos regulatorios: perspectivas del Colaboratorio Cardiovascular EU-MDR
11. Ten‐Year Outcome of Recanalization or Medical Therapy for Concomitant Chronic Total Occlusion After Myocardial Infarction
12. Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory
13. Previous Exercise Levels and Outcome in Patients with New Atrial Fibrillation: ‘Past Achievements Do Not Predict the Future’
14. Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands
15. COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy”
16. Analysis of Differences in Assessment of Left Ventricular Function on Echocardiography and Nuclear Perfusion Imaging
17. Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome
18. Impact of body mass index on outcomes in patients undergoing transfemoral transcatheter aortic valve implantation
19. Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis
20. 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration
21. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: An Analysis of All Appropriate Therapy in the PRAETORIAN trial
22. 1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration
23. ACTION-1: study protocol for a randomised controlled trial on ACT-guided heparinization during open abdominal aortic aneurysm repair
24. Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry
25. 1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score–Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents
26. Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation
27. Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial
28. Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement
29. Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI
30. Causes and predictors of early mortality in patients treated with left ventricular assist device implantation in the European Registry of Mechanical Circulatory Support (EUROMACS)
31. Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2
32. Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial
33. Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration
34. 18F-Fluoride Positron Emission Tomographic Imaging of Penile Arteries and Erectile Dysfunction
35. Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial
36. Bursts of reperfusion arrhythmias occur independently of area at risk size and are the first marker of reperfusion injury
37. Right ventricular systolic function in patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysis
38. Early discontinuation of dual antiplatelet therapy in patients treated with the bio-engineered pro-healing sirolimus-eluting (COMBO) stent
39. Procedural Outcome and Midterm Survival of Lower Risk Transfemoral Transcatheter Aortic Valve Implantation Patients Treated With the SAPIEN XT or SAPIEN 3 Device
40. A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial
41. The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial
42. Impact of Potentially Malignant Incidental Findings by Computed Tomographic Angiography on Long-Term Survival After Transcatheter Aortic Valve Implantation
43. Association of Low-Dose Colchicine With Incidence of Knee and Hip Replacements
44. Anatomical predictors for suture‐based closure of the patent foramen ovale: A multicenter experience
45. IMPACT OF GEOGRAPHICAL VARIATION BETWEEN EUROPE AND ASIA ON CLINICAL OUTCOMES IN PATIENTS WITH HIGH BLEEDING RISK (HBR) AND BIODEGRADABLE-POLYMER SIROLIMUSELUTING CORONARY STENT: A SUBSTUDY OF MASTER DAPT
46. Sex-Related Differences in Sports-Related Sudden Cardiac Death Should Be Reflected in Guideline Screening Recommendations
47. Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial
48. The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia: results from a randomized controlled trial (SURF trial)
49. Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials
50. Risk factors and prognosis of postpericardiotomy syndrome in patients undergoing valve surgery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.